Ad
related to: goldman sachs earnings date
Search results
Is The Goldman Sachs Group (GS) Stock Outpacing Its Finance Peers This Year?
Zacks via Yahoo Finance· 6 days agoSachs (GS) one of those stocks right now? A quick glance at the company's year-to-date performance...
The Goldman Sachs Group, Inc. (GS) To Go Ex-Dividend on May 30th
ETF DAILY NEWS· 6 days agoThe Goldman Sachs Group has raised its dividend by an average of 28.1% per year over the last three years and has increased its dividend annually for the ...
Novartis stock rated 'Buy' by Goldman Sachs, highlighting robust innovation By Investing.com
Investing.com· 4 days agoOn Thursday, Goldman Sachs (NYSE:GS) initiated coverage on Novartis AG (SIX:NOVN) stock, listed as...
The best CD rates in June 2024
CNN.com· 3 days agoWhile CD interest rates are always changing, now is an excellent time to invest because rates are quite high. We’ve done the research to help you find...
Goldman Sachs names global ‘alpha’ stock ideas — and gives one nearly 60% upside
CNBC· 5 days agoGoldman Sachs' list of opportunities include stocks with "deep value" and "defensive growth"...
Goldman Sachs neutral on GlaxoSmithKline stock By Investing.com
Investing.com· 4 days agoOn Thursday, Goldman Sachs (NYSE:GS) initiated coverage on GlaxoSmithKline (NYSE:GSK:LN) (NYSE: GSK...
Decoding Goldman Sachs Gr's Options Activity: What's the Big Picture? - Goldman Sachs Gr (NYSE:GS)
Benzinga· 6 days agoGoldman Sachs Gr With a volume of 663,940, the price of GS is down -0.36% at $459.5. RSI indicators hint that the underlying stock may be overbought. Next ...
Johnson Financial Group Inc. Increases Stock Holdings in The Goldman Sachs Group, Inc. (NYSE:GS)
ETF DAILY NEWS· 6 days agoJohnson Financial Group Inc. boosted its position in shares of The Goldman Sachs Group, Inc. (NYSE:GS – Free Report) by 140.3% in the fourth quarter, according ...
AstraZeneca started at buy at Goldman, which rates GSK a neutral
Morningstar· 4 days agoGoldman Sachs started coverage of AstraZeneca at buy as it rated rival pharmaceutical company GSK a neutral. Analysts led by Rajan Sharma...of 15,200 pence ...
PTC Therapeutics (NASDAQ:PTCT) PT Raised to $32.00 at The Goldman Sachs Group
ETF DAILY NEWS· 4 days agoPTC Therapeutics (NASDAQ:PTCT – Get Free Report) had its target price raised by analysts at The Goldman Sachs Group from $18.00 to $32.00 in a report issued ...